DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
131 hedge funds and large institutions have $391M invested in DIPLOMAT PHARMACY, INC. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 57 increasing their positions, 27 reducing their positions, and 34 closing their positions.
111% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 27
13% more capital invested
Capital invested by funds: $345M → $391M (+$45.5M)
13% less funds holding
Funds holding: 150 → 131 (-19)
44% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 34
75% less call options, than puts
Call options by funds: $568K | Put options by funds: $2.24M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Stephens Inc
Little Rock,
Arkansas
|
+$32.9M |
| 2 |
JP Morgan Chase
New York
|
+$6.12M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$3.41M |
| 4 |
BlackRock
New York
|
+$3.27M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$2.26M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$9.31M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.43M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.99M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.77M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$1.7M |
DPLO Hedge Fund Activity: Q2 2019 in Review
131 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q2 2019, worth a combined $391M — up 13% from $345M a quarter earlier.
Sellers outnumbered buyers: 34 funds closed out of DPLO and 19 opened new positions — a net loss of 15 holders — while 27 trimmed existing stakes and 57 added.
The largest buyer was Stephens Inc, adding an estimated $32.9M. The largest seller was Millennium Management, exiting entirely with an estimated $9.31M sold.
- 131 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q2 2019, down from 150 in Q1 2019.
- Funds reported $391M of DIPLOMAT PHARMACY, INC. stock for Q2 2019, up 13% quarter-over-quarter.
- 19 funds opened new DIPLOMAT PHARMACY, INC. positions in Q2 2019 and 34 closed out, a net change of -15 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q2 2019 was Stephens Inc, an estimated $32.9M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q2 2019 was Millennium Management, an estimated $9.31M sold.
Based on aggregated 13F filings for Q2 2019.